Biotech stocks can be incredibly attractive for risk-taking investors ... Consider when Nvidia made this list on April 15, ...
Novavax incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1.26 per ...
Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...
We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Insider Monkey on MSN1d
The Allstate Corporation (ALL): Navigating Catastrophe Losses and Strategic TurnaroundsWe recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors.
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
The earnings season is in its final week; giants of nifty and sensex have already posted their Q2 results. Today, their 1181 ...
Secures $3.2m in PIPE Financing -- $50m Term Sheet Obtained for Available Financing under Equity Line of Credit -BOSTON and LONDON, Nov. 14, ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces shareholder approval in connection with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback